Variables | None (n = 5) | Mild (n = 8) | Moderate/severe (n = 7) | P value |
---|---|---|---|---|
Age (years) (mean ± SD) | 40.8 ± 8.89 | 47.25 ± 8.84 | 42.29 ± 8.99 | 0.395 |
Sex no. (%) | ||||
 Female | 3 (60) | 6 (75) | 7 (100) | 0.21 |
 Male | 2 (40) | 2 (25) | 0 (0) |  |
Disease duration Median (IQR) | 6 (4–12) | 11.5 (6.5–18.5) | 5 (2–15) | 0.350 |
Morning stiffness/minutes median (IQR) | 60 (60–90) | 120 (60–120) | 120 (60–120) | 0.371 |
Tender joints median (IQR) | 3 (2–6) | 6.5 (3–9.25) | 12 (10–15) | < 0.001** |
Swollen joint median (IQR) | 1 (0–1) | 1 (0–3.75) | 4 (2–5) | 0.013** |
Rheumatoid nodules no. (%) | 1 (20) | 5 (62.5) | 5 (71.4) | 0.2 |
Chest symptoms. (%) | 0 (0) | 2 (25) | 0 (0) | 0.2 |
Sicca symptoms (%) | 0 (0) | 1 (12.5) | 1 (14.3) | 0.7 |
DAS 28 median (IQR) | 4.03 (3.08–4.6) | 4.4 (3.9–5.1) | 5.3 (5.04–6.1) | 0.004** |
Simple Erosion Narrowing Score median (IQR) | 18 (10–28) | 21 (13.3–36.5) | 20 (11–30) | 0.659 |
Hemoglobin (g\dl) | 11.8 ± 1.6 | 11.4 ± 1.3 | 11.01 ± 1.4 | 0.63 |
ESR median (IQR) | 45 (23.5–70) | 47.5 (31.25–107.5) | 70 (30–90) | 0.64 |
CRP median (IQR) | 6 (3.5–38.5) | 12 (6–42) | 6 (5–48) | 0.95 |
RF median (IQR) | 64 (14–173) | 64 (20–117) | 128 (64–128) | 0.71 |
Anti-CCP median (IQR) | 30 (20–139) | 30 (19–90) | 265 (145–355.5) | < 0.001** |